Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of injectable pharmaceuticals, focusing on high-quality, cost-effective solutions for healthcare providers.
With a strong operational presence across North America, Sagent Pharmaceuticals offers a diverse portfolio of products, including generic and specialty injectables that cater to various therapeutic areas. Their commitment to quality and innovation has earned them a solid market position, recognised for their unique approach to sterile injectable manufacturing.
Notable achievements include a robust pipeline of products and strategic partnerships that enhance their capabilities in delivering essential medications. Sagent Pharmaceuticals continues to prioritise patient safety and efficacy, making significant strides in the ever-evolving pharmaceutical landscape.
-20 vs industry average
Sagent Pharmaceuticals, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sagent Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Sagent Pharmaceuticals, Inc. yet.
Sagent Pharmaceuticals, Inc.'s reported carbon emissions
Sagent Pharmaceuticals, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organisation.
In terms of climate commitments, Sagent Pharmaceuticals has not outlined any specific reduction targets or initiatives, nor have they made any public climate pledges. This lack of data and commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
As the pharmaceutical industry increasingly focuses on sustainability, Sagent Pharmaceuticals may benefit from establishing clear emissions reduction goals and participating in recognised initiatives to enhance its environmental performance and transparency.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sagent Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sagent Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Sagent Pharmaceuticals, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project